Laboratory Optimization Tweaks for Sanger Sequencing in a Resource-Limited Setting
AuthorOnwuamah, Chika K
Okwuraiwe, Azuka P
Ahmed, Rahaman A
Sokei, Judith O
Okoli, Leona C
Kagurusi, Brian A
JournalJournal of Biomolecular Techniques : JBT
PublisherAssociation of Biomolecular Resource Facilities
MetadataShow full item record
AbstractDespite various challenges that hinder the implementation of high-tech molecular methods in resource-limited settings, we have been able to implement and achieve International Organization for Standardization 15189:2012 accreditation for genotypic HIV drug resistance testing in our facility. At the Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Nigeria has recorded a high sequencing success rate and good quality sequence data. This was achieved by optimizing laboratory processes from 2008 to the current date. We have optimized sample preparation, RT-PCR, several post-PCR processes, and the cycle sequencing to improve the sensitivity of amplification even with limited plasma samples and low viral copy numbers. The optimized workflow maximizes output, minimizes reagent wastage, and achieves substantial cost savings without compromising the quality of the sequence data. Our performance at our last external quality assurance program is a testimonial to the efficiency of the workflow. For the 5-sample panel, each with 67–68 mutation points evaluated, we scored 100% for all 5 specimens. Our optimized laboratory workflow is thus documented to support laboratories and to help researchers achieve excellent results the first time and eliminate contamination while minimizing the wastage of costly sequencing reagents.
Rights/Terms© Association of Biomolecular Resource Facilities.
HIV drug resistance
reverse transcriptase polymerase chain reaction
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/14217
- A pragmatic approach to HIV-1 drug resistance determination in resource-limited settings by use of a novel genotyping assay targeting the reverse transcriptase-encoding region only.
- Authors: Aitken SC, Bronze M, Wallis CL, Stuyver L, Steegen K, Balinda S, Kityo C, Stevens W, Rinke de Wit TF, Schuurman R
- Issue date: 2013 Jun
- OLA-Simple: A software-guided HIV-1 drug resistance test for low-resource laboratories.
- Authors: Panpradist N, Beck IA, Vrana J, Higa N, McIntyre D, Ruth PS, So I, Kline EC, Kanthula R, Wong-On-Wing A, Lim J, Ko D, Milne R, Rossouw T, Feucht UD, Chung M, Jourdain G, Ngo-Giang-Huong N, Laomanit L, Soria J, Lai J, Klavins ED, Frenkel LM, Lutz BR
- Issue date: 2019 Dec
- Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories.
- Authors: Jackson JB, Drew J, Lin HJ, Otto P, Bremer JW, Hollinger FB, Wolinsky SM
- Issue date: 1993 Dec
- HIV contamination of commercial PCR enzymes raises the importance of quality control of low-cost in-house genotypic HIV drug resistance tests.
- Authors: Monleau M, Plantier JC, Peeters M
- Issue date: 2010
- A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples.
- Authors: Gupta S, Taylor T, Patterson A, Liang B, Bullard J, Sandstrom P, Van Domselaar G, Ji H
- Issue date: 2017